MARZIO, Leonardo
 Distribuzione geografica
Continente #
NA - Nord America 4.716
EU - Europa 4.653
AS - Asia 2.291
Continente sconosciuto - Info sul continente non disponibili 17
OC - Oceania 6
SA - Sud America 5
AF - Africa 3
Totale 11.691
Nazione #
US - Stati Uniti d'America 4.691
CN - Cina 1.051
UA - Ucraina 965
IE - Irlanda 761
TR - Turchia 680
IT - Italia 666
SE - Svezia 626
GB - Regno Unito 523
FR - Francia 413
IN - India 371
DE - Germania 278
FI - Finlandia 182
SG - Singapore 129
RU - Federazione Russa 128
PL - Polonia 37
VN - Vietnam 34
EU - Europa 17
CA - Canada 16
BE - Belgio 15
RO - Romania 14
CZ - Repubblica Ceca 10
GR - Grecia 10
MX - Messico 9
IL - Israele 7
AU - Australia 6
IR - Iran 5
AL - Albania 4
ES - Italia 4
HK - Hong Kong 4
KR - Corea 4
PT - Portogallo 4
AT - Austria 3
CL - Cile 3
NL - Olanda 3
NO - Norvegia 3
TW - Taiwan 3
CH - Svizzera 2
CO - Colombia 2
SC - Seychelles 2
EG - Egitto 1
GE - Georgia 1
ID - Indonesia 1
KH - Cambogia 1
LU - Lussemburgo 1
MD - Moldavia 1
Totale 11.691
Città #
Jacksonville 1.078
Chandler 779
Dublin 749
Dearborn 458
Southend 422
Princeton 386
Izmir 333
Nanjing 327
Wilmington 257
Cambridge 181
Beijing 157
Woodbridge 118
Ann Arbor 113
Ashburn 108
Nanchang 104
Singapore 79
Boardman 65
Shenyang 62
Houston 61
New York 60
Hebei 56
Altamura 54
Kunming 49
Tianjin 46
Jiaxing 44
Rome 40
Kraków 36
Chieti 35
Hangzhou 30
Bologna 25
Jinan 25
Los Angeles 25
Norwalk 24
Grevenbroich 22
Hefei 21
Dong Ket 20
Orange 20
Changsha 19
Guangzhou 19
Washington 16
Düsseldorf 15
Milan 15
Brussels 14
Vinh 14
Augusta 13
Changchun 12
Lanzhou 12
Pescara 11
San Mateo 11
Ningbo 10
Cepagatti 9
Fuzhou 9
Guadalajara 9
Brno 8
L'aquila 8
Moscow 8
Bellante 7
Seattle 7
Zhengzhou 7
Helsinki 6
Kocaeli 6
Tappahannock 6
Toronto 6
Varallo 6
Auburn Hills 5
Edinburgh 5
Leawood 5
Munich 5
Siena 5
Taizhou 5
Turin 5
Villamagna 5
Cedar Knolls 4
Hong Kong 4
Isernia 4
Melbourne 4
Pompei 4
Redwood City 4
Sulmona 4
Walnut 4
Xian 4
Avezzano 3
Baotou 3
Falls Church 3
Frankfurt am Main 3
Haikou 3
Limeil-brévannes 3
Mountain View 3
San Vito al Tagliamento 3
Simi Valley 3
Torrevecchia Teatina 3
Verona 3
Villafranca di Verona 3
Amsterdam 2
Andover 2
Aprilia 2
Ardabil 2
Ardea 2
Armonk 2
Bangalore 2
Totale 6.878
Nome #
Il tempo di transito oro-cecale (TTOC) è accelerato dopo somministrazione orale di allergene alimentare nei pazienti con sindrome del colon irritabile (SCI) e prick test positivo 352
EFFICACY OF TREATMENT WITH PYLERA IN COMBINATION WITH RANITIDINE ON FIRST-LINE INFECTION HELICOBACTER PYLORI: EXPERIENCE OF A SINGLE CENTER 133
A Triple and Quadruple Therapy with Doxycycline and Bismuth for First-Line Treatment of Helicobacter pylori Infection: A Pilot Study 105
Trasmissione di Helicobacter pylori in un modello murino 100
SR140333, a substance P receptor antagonist, influences morphological and motor changes in rat experimental colitis 100
24-hour pancolonic motility using a portable electronic probe in healthy subjects 99
In vitro antimicrobial susceptibility of Helicobacter pylori to nine antibiotics currently used in Central Italy 99
Helicobacter pylori isolates from proximal and distal stomach of patients never treated and already treated show genetic variability and discordant antibiotic resistance. 97
SYMPTOM PATTERN IN FUNCTIONAL DYSPEPSIA AND GASTROESOPHAGEAL REFLUX DISEASE: ROLE OF H. PYLORI INFECTION 95
48-Hour continuous pH measurement in patients with gastro-oesophageal reflux: effect of cisapride. 94
Bovine lactoferrin enhances the efficacy of levofloxacin-based triple therapy as first-line treatment of Helicobacter pylori infection: an in vitro and in vivo study. 94
Heightened free radical activity in angina pectoris 93
Antibacterial effect of plant extracts against Helicobacter pylori 92
Treatment of Helicobacter pylori (Hp) infection with an association of Omeprazole and Roxytromicine: a study in vivo and in vitro. 91
Analysis of genetic variability, antimicrobial susceptibility and virulence markers in Helicobacter pylori identified in Central Italy. 90
L'eritromicina accelera lo svuotamento gastrico e colecistico nell'uomo attraverso un meccanismo mediato dall'acetilcolina 90
Correlation between anal canal size and anal canal pressure: an ultrasonografhip and manometric study 88
Two weeks regimen with amoxillicin, tinidazole and omeprazole eradicates helicobacter pylori and cures active duodenal ulcer 87
Uso razionale di schemi terapeutici nelle infezioni da Helicobacter pylori 86
FUSOBACTERIUM NUCLEATUM (FN) IN PATIENTS AFFECTED BY INFLAMMATORY BOWEL DISEASE 85
Morphological and motor changes during experimental colits in rats are prevented by a specific substance p antagonist 84
ESOPHAGITIS AND ITS CAUSES: WHO IS "GUILTY" WHEN ACID IS FOUND "NOT GUILTY"? 83
Diameters and pressures of the anal canal simultaneously measured with endosonography and manometry 81
Anti-H pylori specific antibody immunoistochemistry improves the diagnostic accuracy of H piylori in biopsy specimen from patients treated with triple therapy 81
Circadian variations in antioxidant defences and lipid peroxidation in the rat heart 81
Effects of combining extracts (from Propolis or Zingiber officinale) with Clarithromycin on H.pylori. 79
MIGRATING MOTOR COMPLEX RECORDED SPONTANEOUSLY AND INDUCED BY MOTILIN AND ERYTHROMYCIN IN AN EX VIVO RABBIT INTESTINAL PREPARATION 79
Triple therapy for 7 days plus omeprazole for 21 days in treatment of active duodenal ulcer with Helicobacte pylori infection. A double blind placebo controlled trial. 78
THE INFLUENCE OF ACID REFLUX ON THE HEART RATE VARIABILITY (HRV) IN PATIENTS WITH AND WITHOUT GASTROESOPHAGEAL REFLUX DISEASE (GERD) 78
Cigarette smoke, ferritin, and lipid peroxidation 78
Short- and long-term omeplazole for the tratment and prevention of duodenal ulcer, and effect on helicobacter pylori 77
Beneficial effects of SR140333, a novel substance P antagonist, in a rat model of experimental colitis 77
Masse all'ipocondrio dx e carcinoma della colecisti 77
COMBINED VIDEOCAPSULE ENDOSCOPY (VCE) AND LACTULOSE HYDROGEN BREATH TEST (LHBT): A COMPARATIVE STUDY TO ASSESS ORO-CECAL TRANSIT TIME (OCTT). 77
Anal canal diameters and pessure measured simultaneously by real time ultrasonography and manometry in human subjects 76
Heparin: does it act as an antioxidant in vivo? 76
TYPICAL AND ATYPICAL SYMPTOMS OF GASTRO ESOPHAGEAL REFLUX DISEASE: DOES Helicobacter pylori MATTER? 76
null 76
Detection of Helicobacter pylori in the gastrointestinal tract of Balb/C euthymic mice infected by human Helicobacter pylori and evidence for transmission 75
Anti-Helicobacter pylori specific antibody immunohistochemistry improves the diagnostic accuracy of Helicobacter pylori in biopsy specimen from patients treated with triple therapy.Am. J. Gastroenterol 75
Effect of ischemia and reperfusion on antioxidant enzymes and mitochondrial inner membrane proteins in perfused rat heart. 75
Coccoid Helicobacter pylori not culturable in vitro reverts in mice. 75
H2-RECEPTOR ANTAGONISTS ARE SCAVENGERS OF OXYGEN RADICALS 75
TRANSIENT LOWER ESOPHAGEAL SPHINCTER RELAXATIONS AND GASTRO-ESOPHAGEAL REFLUX EPISODES IN HEALTHY SUBJECTS AND GERD PATIENTS DURING 24 HOURS 75
Detection of Helicobacter pylori in saliva and esophagus 75
EFFECT OF CLEBOPRIDE ON ESOPHAGEAL MOTOR FUNCTION IN GERD PATIENTS WITH INEFFECTIVE ESOPHAGEAL MOTILITY: EVALUATION USING HIGH RESOLUTION MANOMETRY 75
EVALUATION OF INTRAPARENCHYMAL AND PORTAL BLOOD FLOW BY CONTRAST ENHANCED ULTRASOUND (CEUS) AND LIVER STIFFNESS BY FIBROSCAN IN NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND CHRONIC HEPATITIS C (CHC) 75
Swallows, oesophageal and gastric motility in normal subjects and in patients with gastro-oesophageal reflux disease: a 24-h-pH-manometric study 74
EVALUATION OF INTRAPARENCHYMAL AND PORTAL BLOOD FLOW BY CONTRAST ENHANCED ULTRASOUND (CEUS) AND LIVER STIFFNESS BY FIBROSCAN IN NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND CHRONIC HEPATITIS C (CHC). 74
Effects of cimetropium bromide on gallbladder contraction in response to oral and intraduodenal olive oil. 74
Alterazioni contrattili della muscolatura liscia nel corso di colite sperimentale sono ridotte da un antagonista specifico della sostanza P 74
Esophageal and gastric motility in patients with gastroesophageal reflux disease 73
Evidence for an oro-fecal transmission inan experimental murine model of helicobacter pylori infection. 73
Effect of glyceryl trinitrate ointment (GTO) 0.2% and 2% on anal canal pressure during acute and chronic application in patients with anal fissure 73
Role of antimicrobial susceptibility testing on efficacy of triple therapy in Helicobacter pylori eradication. 73
LA MALDIGESTIONE 73
SHORT AND LONG TERM EFFICACY OF GLYCERYL TRINITRATE (GTN) OINTMENT 0.2% AND 2% ON ANAL CANAL PRESSURE IN PATIENTS WITH CHRONIC ANAL FISSURES. 73
Role of U.S. and oral colecistography in pre-operative diagnostic approach to cholelithiasis 73
THE INFLUENCE OF ACID REFLUX ON THE HEART RATE VARIABILITY (HRV) IN PATIENTS WITH AND WITHOUT GASTROESOPHAGEAL REFLUX DISEASE (GERD). 73
Blood cardioplegia reduces oxidant burden in the ischemic and reperfused human myocardium 73
GRAVIDANZA IN UNA PAZIENTE AFFETTA DA RETTOCOLITE ULCEROSA IN TERAPIA CON INFLIXIMAB: CASO CLINICO 72
Gastric antral and fundus receptive relaxation in dyspeptic patients and normal subjects 71
Identification of a novel mutation affecting domain V of the 23S rRNA gene in Helicobacter pylori 71
Regional distribution of glutathione-related antioxidant defences in the normal rabbit aorta. 70
5-HT1-RECEPTOR AGONIST SUMATRIPTAN MODIFIES GASTRIC SIZE AFTER 500 ML OF WATER IN DYSPEPTIC PATIENTS AND NORMAL SUBJECTS 69
Pharyngeal, Esophageal and Gastric Motility in Normal Subjects and in patients with gastroesophageal Reflux Disease 68
EFFICACIA E SICUREZZA DEL RITRATTAMENTO CON INFLIXIMAB IN UN PAZIENTE AFFETTO DA MORBO DI CROHN 68
Effect of omeprazole, clarithromicin and amoxicillin for a short time on helicobacter pylori eradication 67
Distensione gastrica nei soggetti normali e nei pazienti dispeptici helicobacter pylori positivi e negativi e correlazione con i sintomi 67
La terapia chirurgica laparoscopica della malattia da reflusso gastro-esofageo 67
I RILASCIAMENTI TRANSITORI DELLO SFINTERE ESOFAGEO INFERIORE NELLA GENESI DEI REFLUSSI GASTRO-ESOFAGEI: PROSPETTIVE TERAPEUTICHE 67
EFFECT OF HYOSCINE N-BUTYLBROMIDE ON GASTROESOPHAGEAL REFLUX IN NORMAL SUBJECTS AND PATIENTS WITH GASTROESOPHAGEAL REFLUX DISEASE. 67
EVALUATION OF LIVER BLOOD FLOW AND FIBROSIS IN PATIENTS WITH NON ALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND CIRRHOSIS IN COMPARISON WITH NORMAL CONTROLS THROUGH CONTRAST ENHANCED ULTRASOUND(CEUS) AND FIBROSCAN 67
Mouth to caecum transit time (MCTT) is accellerated after oral food antigen in patients with irritable bowel syndrome 67
SPONTANEOUS OPENING OF LES IN ACHALASIA: AN UNCOMMON ON-LINE DOCUMENTATION BY HIGH-RESOLUTION MANOMETRY 67
ESOPHAGEAL MOTILITY ASSESSMENT AFTER PRUCALOPRIDE ADMINISTRATION IN PATIENTS WITH INEFFECTIVE ESOPHAGEAL MOTILITY (IEM) AND SYSTEMIC SCLEROSIS. 67
Oesophageal and gastric motility in patients with gastro-oesophageal reflux disease 66
Role of transient lower esophageal sphincter relaxations in the genesis of priximal gastro-esophageal reflux 66
Proximal and Distal Gastric Distension in Normal Subjects and H.pylori-Positive and -Negative Dyspeptic Patients and Correlation with Symptoms 66
Influence of physical activity on gastric emptying of liquids in normal human subjects 66
EFFECT OF THE 5-HT1 AGONIST SUMATRIPTAN ON ESOPHAGEAL MOTOR PATTERN IN PATIENTS WITH INEFFECTIVE ESOPHAGEAL MOTILITY 66
EFFECT OF AN ACUTE INTRALUMINAL ADMINISTRATION OF CAPSAICIN ON OESOPHAGEAL MOTOR PATTERN IN GORD PATIENTS WITH INEFFECTIVE OESOPHAGAL MOTILITY 66
EVALUATION OF FIBROSIS AND INTRAPARENCHIMAL BLOOD FLOW INCHIRROTIC PATIENTS, CHRONIC ACTIVE HEPATITIS AND NORMAL CONTROLS THROUGH FIBROSCAN AND ULTRASOUND ENHANCED CONTRAST MEDIA. 66
DISORDINI MOTORI ASPECIFICI DELL’ESOFAGO 65
EFFECT OF CIMETROPIUM BROMIDE ON GALLBLADDER CONTRACTION IN RESPONSE TO ORAL AND INTRADUODENAL OLIVE OIL 65
Aortic glutathione-related antioxidant defences in rabbits subjected to suprarenal aortic coarctation hypertension 65
Detection of Helicobacter pylori in esophagus and saliva in humans 65
CAN HELICOBACTER PYLORI INFECTION HAVE A ROLE ON CLINICAL APPEARANCE OF GERD? 65
Changes in the myocardial enzymatic systems (AES) induced by ischemia-reperfusion in the isolated rat heart 65
EFFECT OF THE 5-HT3 RECEPTOR ANTAGONIST, ONDANSETRON, ON GASTRIC SIZE IN DYSPEPTIC PATIENTS WITH IMPAIRED GASTRIC ACCOMODATION 64
GASTRIC AND GALLBLADDER EMPTYING AFTER STANDARD SOLID MEAL IN NORMAL CONTROLS, PATIENTS WITH “MOTILITY-LIKE” DYSPEPSIA AND EFFECT OF DOMPERIDONE. 64
THE VALUE OF CONTRAST ENHANCED ENDOSCOPIC ULTRASOUND IN THE FINE NEEDLE ASPIRATION 64
Registrazione delle 24 ore della motilità del piloro in soggetti normali 63
Gastric antral and fundic distention evaluated by ultrasonography (US) in normal subjects and patients with idiopathic dyspepsia 63
ROLE OF PRUCALOPRIDE (RESOLOR) IN THE SETTING-UP OF PILLCAM COLON-CAPSULE ENDOSCOPY (CCE). EXPERIENCEFROM A SINGLE CENTRE 63
ULTRASOUND(US) GRADED HEPATOSTEATOSIS ASSESSMENT THROUGH CONTRAST ENHANCED ULTRASOUND (CEUS) AND FIBROSCAN IN NON ALCOHOLIC FATTY LIVER DISEASE 62
Gastric and gallbladder emptyng in dyspeptic patients with Helicobacter pylori positive (Hp+) and negative (HP-) antral gastritis: effect of Omeprazole. 62
Prolonged anal sphincter manometry in normal human subjects 61
Rifabutin based triple therapy for eradication of H.pylori primary and secondary resistant to tinidazole and clarithromycin 61
TRANSIENT LOWER ESOPHAGEAL SPHINCTER RELAXATIONS PLAY AN INSIGNIFICANT ROLE IN GASTRO-ESOPHAGEAL REFLUX TO THE PROXIMAL ESOPHAGUS 61
Totale 7.844
Categoria #
all - tutte 38.343
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.343


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.875 0 176 11 90 215 333 380 285 37 124 224 0
2020/20211.118 187 5 188 10 87 239 14 18 80 190 23 77
2021/2022794 28 12 6 200 75 9 10 65 55 6 89 239
2022/20232.220 199 234 122 268 186 514 150 160 259 29 54 45
2023/20241.019 77 52 65 29 33 313 252 40 3 41 17 97
2024/2025197 189 8 0 0 0 0 0 0 0 0 0 0
Totale 11.949